[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.166.89.187. Please contact the publisher to request reinstatement.
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]
Views 512
Citations 0
Correction
January 25, 2012

Table Error in: Association of BRCA1 and BRCA2 Mutations With Survival, Chemotherapy Sensitivity, and Gene Mutator Phenotype in Patients With Ovarian Cancer

JAMA. 2012;307(4):363. doi:10.1001/jama.2012.13

Table Error: In the Original Contribution “Association of BRCA1 and BRCA2 Mutations With Survival, Chemotherapy Sensitivity, and Gene Mutator Phenotype in Patients With Ovarian Cancer,” published in the October 12, 2011, issue of JAMA (2011;306[14]:1557-1565), an incorrect proportion was listed in Table 1. In the column describing BRCA1 mutation cases, the number (%) of those with residual tumor size of less than 1 cm should be 15 (50). This article was corrected online. An accompanying letter to the editor appears in this issue of JAMA.

×